MannKind completes follow-on

MannKind Corp. (NASDAQ:MNKD), Valencia, Calif. Business: Endocrine/Metabolic, Cancer Date completed: 10/18/12 Type: Follow-on Raised: $80 million Units: 40 million Price: $2 (unit) Shares after offeri...